Volume 31, Issue 1 (April 2020)                   Studies in Medical Sciences 2020, 31(1): 40-52 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fenjanchi-Rahnema L, Bagheri M, pishkar L, Abdi-rad I, Nanbakhsh F. ASSOCIATION OF ADIPONECTIN +45 T/G POLYMORPHISM WITH THE RISK OF POLYCYSTIC OVARY SYNDROME IN WOMEN FROM WEST AZERBAIJAN PROVINCE, IRAN. Studies in Medical Sciences 2020; 31 (1) :40-52
URL: http://umj.umsu.ac.ir/article-1-4985-en.html
Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran. , mortazabagheri@yahoo.com
Abstract:   (2440 Views)
Background & Aims: Polycystic ovary syndrome is the most common cause of infertility and is characterized by the lack of ovulation and hyperandrogenism. The prevalence of polycystic ovary syndrome among Iranian women is 14.6%. Several polycystic ovary syndrome susceptible gene variants have been identified so far. The results of various studies are inconsistent. Due to drug side effects and high cost of treatment, this study was designed to manage patients. In this study, the association of adiponectin +45 T/G polymorphism with the risk of polycystic ovary syndrome in women from West Azerbaijan Province (Iran) was evaluated.
 Materials & Methods: This study was performed in two groups of patients and controls. 3 ml of peripheral blood was collected from the participants in the study. Saturated salt method was used to extract genomic DNA. PCR-RFLP method was used to determine polymorphisms.
Results: The mean age of the participants was 25.03±3.6 in the patient group and 27.01 ± 4.8 in the control group. All the patients who participated in this study had average obesity with a body mass index of 26.04±3.9. All patients were hirsute. In this study, no significant differences were observed between the case and control groups regarding genotypic and allelic frequencies. The observed alleles and genotypes of ADIPOQ +45 (T / G) were in Hardy-Weinberg equilibrium in the control group. Chi-square and p-values with two degrees of freedom are 3.2 (<3.84) and 0.1, respectively.
Conclusion: ADIPOQ +45 (T / G) gene polymorphism is not a risk factor for polycystic ovary syndrome in women of West Azerbaijan Province. Investigation of other risk factors related to genetic and environmental factors and their interaction with each other is recommended.
Full-Text [PDF 2891 kb]   (753 Downloads)    
Type of Study: Research | Subject: ژنتیک

References
1. Crespo RP, Bachega TA, Mendonça BB, Gomes LG. An update of genetic basis of PCOS pathogenesis. Arch Endocrinol Metab2018; 62(3):352-61. [DOI:10.20945/2359-3997000000049] [PMID]
2. Cavalcante MB, Sarno M, Cavalcante CT, Júnior EA, Barini R. Coagulation Biomarkers in Women with Recurrent Miscarriage and Polycystic Ovarian Syndrome: Systematic Review and Meta-Analysis. Geburtshilfe Frauenheilkd2019; 79(07):697-704. [DOI:10.1055/a-0884-3212] [PMID] [PMCID]
3. Arachchillage DR, Makris M. Inherited thrombophilia and pregnancy complications: should we test? Semin Thromb Hemost 2019; 45(1):50-60. [DOI:10.1055/s-0039-1678545] [PMID]
4. Khan A, Karim N, Ainuddin JA, Fahim MF. Polycystic Ovarian Syndrome: Correlation between clinical hyperandrogenism, anthropometric, metabolic and endocrine parameters. Pak J Med Sci2019; 35(5):1227. [DOI:10.12669/pjms.35.5.742]
5. Conway GS, Agarwal R, Betteridge DJ, Jacobs HS Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992; 37(2):119-25. [DOI:10.1111/j.1365-2265.1992.tb02295.x] [PMID]
6. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215. [DOI:10.1093/nar/16.3.1215] [PMID] [PMCID]
7. Ranjzad F, Mahban A, Shemirani AI, Mahmoudi T, Vahedi M, Nikzamir A, et al. Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. J Assist Reprod Genet 2011; 28(3): 225-32. [DOI:10.1007/s10815-010-9506-4] [PMID] [PMCID]
8. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89:2745-9. https://doi.org/10.1210/jcem.89.9.9990 [DOI:10.1210/jc.2003-032046] [PMID]
9. Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008; 26:72-84. [DOI:10.1055/s-2007-992927] [PMID]
10. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90:1929-35. [DOI:10.1210/jc.2004-1045] [PMID]
11. Diamanti-Kandarakis E, Economou F. Stress in women: metabolic syndrome and polycystic ovary syndrome. Ann N Y Acad Sci 2006; 1083:54-62. [DOI:10.1196/annals.1367.006] [PMID]
12. Essah PA, Wickham EP, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. Clin Obstet Gynecol 2007; 50:205-25. [DOI:10.1097/GRF.0b013e31802f3547] [PMID]
13. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148:293-300. [DOI:10.1530/eje.0.1480293] [PMID]
14. Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 2000; 24: 861-8. [DOI:10.1038/sj.ijo.0801244] [PMID]
15. Filippi E, Sentinelli F, Trischitta V, et al. Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 2004; 12:199-205. [DOI:10.1038/sj.ejhg.5201120] [PMID]
16. Kaya C, Pabuccu R, Cengiz SD, Dunder I. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: a prospective, randomized study. Exp Clin Endocrinol Diabetes 2010; 118:161-6. [DOI:10.1055/s-0029-1220770] [PMID]
17. Menzaghi C, Ercolino T, Di Paola R, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51:2306-12. [DOI:10.2337/diabetes.51.7.2306] [PMID]
18. Tumvoll M, Tschritter O, Fritsche A, et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002; 51:37-41. [DOI:10.2337/diabetes.51.1.37] [PMID]
19. Zhang N, Shi YH, Hao CF, Gu HF, Li Y, Zhao YR, Wang LC, Chen ZJ. Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women. Eur J Endocrinol 2008; 158: 255-60. [DOI:10.1530/EJE-07-0576] [PMID]
20. Xita N, Georgiou I, Chatzikyriakidou A, Vounatsou M, Papassotiriou GP, Papassotiriou I, Tsatsoulis A. Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 2005; 51(2):416-23. [] [PMID]
21. Ranjzad F, Mahmoudi T, IraniShemirani A, Mahban A, Nikzamir A, Vahedi M, Ashrafi M, Gourabi H. A common variant in the adiponectin gene and polycystic ovary syndrome risk. Mol Biol Rep 2012; 39 (3):2313-9. [] [PMID]
22. Alfaqih MA, Khader YS, Al-Dwairi AN, Alzoubi A, Al-Shboul O, Hatim A. Lower Levels of Serum Adiponectin and the T Allele of rs1501299 of the ADIPOQ Gene Are Protective against Polycystic Ovarian Syndrome in Jordan. Korean J Fam Med 2018; 39(2):108-13. [] [PMID] [PMCID]
23. Alfaqih MA, Al-Mughales F, Al-Shboul O, Al Qudah M, Khader YS, Al-Jarrah M. Association of Adiponectin and rs1501299 of the ADIPOQ Gene with Prediabetes in Jordan. Biomolecules 2018; 8(4): pii: E117. doi: 10.3390/biom8040117. [DOI:10.3390/biom8040117] [PMID] [PMCID]
24. Ramezani Tehrani F, Daneshpour M, Hashemi S, Zarkesh M, Azizi F.Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS. Iran J Reprod Med 2013; 11(3):185-94. [PMID] [PMCID]
25. Demirci H, Yilmaz M, Ergun MA, Yurtcu E, Bukan N, Ayvaz G. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters. Gynecol Endocrinol 2010; 26(5):348-55. [DOI:10.3109/09513590903367051] [PMID]
26. Nambiar V, Vijesh VV, Lakshmanan P, Sukumaran S, Suganthi R. Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2016; 200:82-8. [DOI:10.1016/j.ejogrb.2016.02.031] [PMID]
27. Jia H, Yu L, Guo X, Gao W, Jiang Z.Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis. Endocrine 2012; 42(2):299-306. [DOI:10.1007/s12020-012-9605-3] [PMID]
28. Zhang W, Wei D, Sun X, Li J, Yu X, Shi Y, Chen ZJ. Family-based analysis of adiponectin gene polymorphisms in Chinese Han polycystic ovary syndrome. Fertil Steril 2014; 101(5): 1419-23. [DOI:10.1016/j.fertnstert.2014.01.035] [PMID]
29. Xian L, He W, Pang F, Hu Y. ADIPOQ gene polymorphisms and susceptibility to polycystic ovary syndrome: a HuGE survey and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2012; 161(2):117-24. [DOI:10.1016/j.ejogrb.2011.12.017] [PMID]
30. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet 2004; 20:439-44. [DOI:10.1016/j.tig.2004.06.014] [PMID]
31. San Millan JL, Corton M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 2004;89: 2640-6. [DOI:10.1210/jc.2003-031252] [PMID]
32. Panidis D, Kourtis A, Kukuvitis A, et al. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of delta4-androstenedione. Hum Reprod 2004; 19:1728-33. [DOI:10.1093/humrep/deh336] [PMID]
33. Haap M, Machicao F, Stefan N, et al. Genetic determinants of insulin action in polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2005; 113: 275-81. [DOI:10.1055/s-2005-837665] [PMID]
34. Heinonen S, Korhonen S, Helisalmi S, et al. Associations between two single nucleotide polymorphisms in the adiponectin gene and polycystic ovary syndrome. Gynecol Endocrinol 2005; 21:165-9. [DOI:10.1080/09513590500238796] [PMID]
35. Xita N, Georgiou I, Chatzikyriakidou A, et al. Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 2005; 51:416-23. [DOI:10.1373/clinchem.2004.043109] [PMID]
36. Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, et al. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod 2006; 21:2257-65. [DOI:10.1093/humrep/del146] [PMID]
37. Zhang N, Shi YH, Hao CF, et al. Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women. Eur J Endocrinol 2008; 158:255-60. [DOI:10.1530/EJE-07-0576] [PMID]
38. Yoshihara K, Yahata T, Kashima K, Mikami T, Tanaka K. Association of single nucleotide polymorphisms in adiponectin and its receptor genes with polycystic ovary syndrome. J Reprod Med 2009; 54:669-74. [PMID]
39. Li L, Yun JH, Lee JH, Song S, Choi BC, Baek KH. Association study of+45G15G (T/ G) and +276(G/T) polymorphisms in the adiponectin gene in patients with polycystic ovary syndrome. Int J Mol Med 2011; 27:283-7. [DOI:10.3892/ijmm.2010.565]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Studies in Medical Sciences

Designed & Developed by : Yektaweb